Showing results (91-100 of 250) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|July 17, 2012
AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cellsPavithra Raghavan, Vasu Tumati, Lan Yu, et al.
Neoplasia (New York, N.Y.)|June 14, 2016
Role of Autophagy as a Survival Mechanism for Hypoxic Cells in TumorsQian Tan, Marina Wang, Man Yu, et al.
Bioinformatics (Oxford, England)|November 8, 2017
NanoStringNormCNV: pre-processing of NanoString CNV dataDorota H Sendorek, Emilie Lalonde, Cindy Q Yao, et al.
The Prostate|May 21, 2016
Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal TherapyCheng S Jin, Marta Overchuk, Liyang Cui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2017
Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancerNicola J Nasser, John Thoms, Antoninus Soosaipillai, et al.
International Journal of Radiation Biology|September 4, 2009
Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancerSupriya Chopra, Warren D Foltz, Michael F Milosevic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 7, 2015
Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cellsRamya Kumareswaran, Naz Chaudary, Karolina Jaluba, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 20, 2005
Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cellsAlice X Meng, Farid Jalali, Andrew Cuddihy, et al.
BMC Medical Genetics|July 22, 2008
Analysis of variants in DNA damage signalling genes in bladder cancerAnanya Choudhury, Faye Elliott, Mark M Iles, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersDanny Vesprini, Steven A Narod, John Trachtenberg, et al.
Pageof 25